Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
Moderate alcohol use is not strictly forbidden with Farxiga (dapagliflozin), but adults over 65 face higher risks because alcohol can amplify dehydration, low blood pressure, dizziness, and fall risk that this SGLT2 inhibitor already makes more likely. Heavy or binge drinking is the bigger concern, as it can trigger dangerously low blood sugar (especially if you also take insulin or a sulfonylurea) and raise the risk of ketoacidosis, which can occur even when blood sugar looks normal. Kidney function, other medications, and how much you eat and drink alongside alcohol all change the picture. There are several important factors and warning signs to consider, so see below to understand more before assuming an occasional drink is safe for you.
If you are unsure whether your symptoms after drinking are harmless or a sign of dehydration, hypoglycemia, or ketoacidosis, a free, instant, online symptom check can help you sort out what is likely going on and decide whether to monitor at home, call your prescriber, or seek urgent care.
Last reviewed for medical accuracy: 09/13/2026
Farxiga (dapagliflozin) is a sodium-glucose co-transporter-2 (SGLT2) inhibitor commonly prescribed to manage type 2 diabetes, heart failure and chronic kidney disease. If you’re over 65 and taking Farxiga, you may wonder whether it’s safe to drink alcohol. This guide covers what you need to know, based on clinical data and prescribing information, so you can make informed choices—and always remember to speak to your doctor about anything life-threatening or serious.
Why Alcohol and Farxiga Interaction Matters
Farxiga works by helping your kidneys excrete excess glucose in urine. Alcohol can affect blood sugar levels and fluid balance, and both factors change as we age. Combining alcohol with Farxiga may:
Understanding Farxiga’s Effects
As you get older, kidney function and fluid reserves naturally decline, so these side effects can become more pronounced.
How Alcohol Impacts Older Adults
Key Risks When Combining Alcohol with Farxiga
Hypoglycemia
Dehydration and Hypotension
Kidney Stress
Exacerbated Side Effects
Guidelines for Drinking Alcohol While on Farxiga
You don’t necessarily have to give up alcohol entirely, but it’s wise to follow these precautions:
Discuss First
Limit Quantity
Time It Right
Stay Hydrated
Monitor Blood Sugar
Watch for Warning Signs
Avoid Binge Drinking
When to Avoid Alcohol Completely
There are scenarios where you should skip alcohol:
Practical Tips for Safe Enjoyment
Free, Online Symptom Check
If you ever feel uncertain about symptoms—dizziness, extreme thirst, confusion—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/). It’s a convenient way to get clarity on what might be happening and whether you need medical care.
Final Thoughts
Drinking alcohol in moderation can be compatible with Farxiga therapy in many people over 65, provided you:
Above all, speak to a doctor about any symptom that feels serious or could be life-threatening. Your provider can tailor advice to your health history, kidney function and other medications—helping you balance quality of life with safety.
(References)
* Yoshioka H, Ohishi R, Hirose Y, Torii-Goto A, Park SJ, Miura N, Yoshikawa M. Chronopharmacology of dapagliflozin-induced antihyperglycemic effects in C57BL/6J mice. Obes Res Clin Pract. 2019 Sep-Oct;13(5):505-510. doi: 10.1016/j.orcp.2019.08.001. Epub 2019 Aug 26. PMID: 31466832.
* Sujanani SM, Elfishawi MM, Zarghamravanbaksh P, Castillo FJC, Reich DM. Dapagliflozin-Induced Acute Pancreatitis: A Case Report and Review of Literature. Case Rep Endocrinol. 2020;2020:6724504. doi: 10.1155/2020/6724504. Epub 2020 Feb 14. PMID: 32123591; PMCID: PMC7044483.
* Highlights From the Circulation Family of Journals. Circulation. 2021 Jan 26;143(4):389-394. doi: 10.1161/CIRCULATIONAHA.120.053435. Epub 2021 Jan 25. PMID: 33493028.
* Wu Y, Song P, Yuan X, Li D. Exploring the Effect of Dapagliflozin on Alcoholic Kidney Injury and Renal Interstitial Fibrosis in Rats Based on TIMP-1/MMP-24 Pathway. Evid Based Complement Alternat Med. 2021;2021:6538189. doi: 10.1155/2021/6538189. Epub 2021 Oct 21. PMID: 34721639; PMCID: PMC8553464.
* Wallenius K, Kroon T, Hagstedt T, Löfgren L, Sörhede-Winzell M, Boucher J, Lindén D, Oakes ND. The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis. J Lipid Res. 2022 Mar;63(3):100176. doi: 10.1016/j.jlr.2022.100176. Epub 2022 Feb 2. PMID: 35120993; PMCID: PMC8953658.
* Salama RM, Ahmed RH, Farid AA, AbdElSattar BA, AbdelBaset RM, Youssef ME, El Wakeel SA. Gastroprotective effect of dapagliflozin in ethanol-induced gastric lesions in rats: Crosstalk between HMGB1/RAGE/PTX3 and TLR4/MyD88/VEGF/PDGF signaling pathways. Int Immunopharmacol. 2023 Feb;115:109686. doi: 10.1016/j.intimp.2023.109686. Epub 2023 Jan 7. PMID: 36623411.
* Wu G, Wu S, Tang J, Wu H. Delayed euDKA Associated With Dapagliflozin After Pancreatitis. Clin Ther. 2023 Jul;45(7):e167-e170. doi: 10.1016/j.clinthera.2023.05.006. Epub 2023 May 27. PMID: 37248092.
* Garcia-Pagan JC, Gluud LL, Mandorfer M, Schattenberg JM, De Gottardi A, Berzigotti A, Fortea JI, Martínez AA, Alvarado-Tapias E, Berning M, Petryszyn P, Henricson E, Berglind N, Lin M, Persson K, Mercier AK, Ambery P, Bosch J, Oscarsson J, Rockey DC. Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study. Br J Clin Pharmacol. 2026 May;92(5):1326-1338. doi: 10.1002/bcp.70332. Epub 2025 Dec 8. PMID: 41362018.
* Abdullah S, Thiab S, Altamimi AA, Al-Masud AA, Faludah SF, Abdulhameed AS. A repurposing Dapagliflozin via polymeric nanogels for colorectal cancer therapy. Sci Rep. 2026 Jan 17;16(1):5625. doi: 10.1038/s41598-026-36232-8. Epub 2026 Jan 17. PMID: 41548021; PMCID: PMC12891543.
* Demirtas C, Kılıç Ş, Babaoğlu M, Asal S, Tenekeci EG, Beyaztaş H, Guler EM, Erguven SP, Sevgin K. Effective Protection Against Alcohol-Related Cardiac Damage: Dapagliflozin. J Cardiovasc Pharmacol. 2026 Sep 4. doi: 10.1097/FJC.0000000000001877. Epub 2026 Sep 4. PMID: 42696673.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.